Johnson & Johnson vs McKesson Corporation
JNJ vs MCK — side-by-side comparison from reported financials. JNJ leads 4, MCK leads 7 of 11 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
McKesson Corporation
MCK · Healthcare
$938.84+0.92%Solid
| Metric | JNJ | MCK |
|---|---|---|
| Price | $261.79 | $938.84 |
| Market cap | $631B | $109B |
| Revenue (TTM) | $97.9B | $411B |
| Revenue growth | +5.6% | +13.4% |
| Net margin | 21.5% | 1.1% |
| Free cash flow | $22.2B | $6.42B |
| Net cash (debt) | ($27.8B) | ($4.81B) |
| 1-year price return | +37.0% | +23.9% |
| P/E | 29.9 | 23.8 |
| P/E vs own history (cheap-side %) | 16% | 59% |
| Dividend yield | 2.00% | 0.36% |
| Return on equity | 26% | 39% |
| Altman Z-score | — | 2.25 |
| CV checks passed | 10 of 11 | 11 of 11 |
| Employees | 140,800 | 43,000 |
Full résumé-style profiles: JNJ CV · MCK CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.